Research
At CCfV, we are committed to advancing national and global knowledge and prevention of infectious disease through multidisciplinary research.
Our Research
Our research is organized into three groups: Vaccine Discovery, Vaccine Evaluation, and Policy, Programs, and Implementation. While each group has its focus, their collaboration fosters a cohesive approach to advancing vaccine development and public health initiatives.
Together, we work towards innovative solutions that can make a real impact on disease prevention.
Research Groups
Vaccine Discovery Group
The Vaccine Discovery Group is a collaborative team of researchers dedicated to advancing the basic sciences that lay the foundations for vaccinology and immunology. Our team brings together experts from bacteriology, molecular biology, virology, and immunology and other related disciplines. This multidisciplinary appr...
Read More
Vaccine Evaluation Group
The Vaccine Evaluation Group is dedicated to every stage of vaccine research, from initial clinical trials to comprehensive program assessments, specializing in developing and conducting first-in-human phase 1 studies, as well as post-licensure phase 4 trials. The Evaluation Group works with external partners to evalua...
Read More
Policy, Programs, and Implementation (PPI) Group
The Policy, Programs, and Implementation Group offers cross-cutting expertise in health law, bioethics, policy development, and social sciences. This diverse skill set enables the team to assess the potential public impact of new vaccines and technologies, guiding research during both the discovery and evaluation stage...
Read More
Transparency Statements
Funding
Our work is partially funded through competitive academic, government and industry research grants. We also conduct clinical trials of novel vaccines on a contractual basis for the manufacturers of the product, who provide funding to support these trials.
External Regulatory Approval
Our research must meet the rigorous standards of the Research Ethics Board at our partner institutions (IWK Health, Dalhousie University, or Nova Scotia Health) as well as the national oversight of TCPS 2. These regulatory bodies ensure that CCfV research is conducted with high integrity and quality, and meet thorough standards that protect the safety and wellbeing of participants.
